Abstract
Conventional chemotherapy has not proven effective in improving long-term results of surgery for liver metastases from colorectal cancer. We assessed the usefulness of immunotherapy with tumor infiltrating lymphocytes (TIL) plus Interleukin-2 (IL-2) as adjuvant treatment. Between 1995 and 1998, 47 patients were enrolled onto a prospective protocol; 25 entered the treatment group (A) and 22 entered the control group (B). All patients had undergone radical liver resection. TIL obtained from surgical specimens from group A patients were cultured and activated in vitro with IL-2, then reinfused into the patients with IL-2. We investigated pre- and post-IL-2 stimulation expression of T cell receptor (TCR) zeta- and epsilon-chains, p56(lck), Fas, and Fas-L by TIL immunostaining. Fourteen patients from group A (56%) received immunotherapy; 14 from group B (60%) underwent conventional chemotherapy, and the remaining 19 patients did not receive any treatment. No significant differences between the two groups were found in the actuarial and disease-free survival (DSF) rates after 1, 3, and 5 years. After IL-2 exposure, TCR zeta-chain expression significantly increased (P = 0.001); An increase in TCR epsilon-chain expression (P = 0.04), a...Continue Reading
References
Jan 1, 1992·Biotherapy·T L Whiteside
Jun 1, 1992·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P A PalmerC R Franks
Jul 1, 1991·Cancer·R O DillmanJ Arnold
Dec 1, 1987·Annals of Surgery·A E ChangS M Steinberg
Aug 24, 1987·Journal of Immunological Methods·S L TopalianS A Rosenberg
Apr 9, 1987·The New England Journal of Medicine·W H WestR K Oldham
Nov 17, 1995·Science·T S GriffithT A Ferguson
Aug 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P S GoedegebuureT J Eberlein
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·B Gansbacher
Oct 1, 1994·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·R S FreedmanS Templin
Jul 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D J SchwartzentruberS L Topalian
Aug 3, 1994·Journal of the National Cancer Institute·S A RosenbergD E White
Jul 1, 1994·Cancer Immunology, Immunotherapy : CII·T L Whiteside, G Parmiani
Mar 15, 1994·Cancer·B A PockajJ C Yang
May 1, 1994·Cancer Immunology, Immunotherapy : CII·D J ColeY C Yang
Jun 15, 1993·Cancer·G H Ballantyne, J Quin
Jan 1, 1996·Immunology Today·K ZierS Salvadori
Jul 15, 1996·Cancer·G B RattoG Melioli
May 1, 1997·Archives of Surgery·R L JamisonD M Ilstrup
Mar 12, 1998·World Journal of Surgery·B OhlssonK G Tranberg
Jul 22, 1998·Cancer Immunology, Immunotherapy : CII·T L Whiteside, H Rabinowich
Jan 1, 1999·Nature·R M PittiA Ashkenazi
Jan 23, 1999·Current Opinion in Oncology·N P Restifo, S A Rosenberg
Sep 29, 1999·Cancer Immunology, Immunotherapy : CII·T L Whiteside
Oct 7, 2000·Lancet·T TakayamaT Kakizoe
Oct 4, 2002·Archives of Surgery·Giorgio ErcolaniAntonino Cavallari
Mar 1, 2003·British Journal of Cancer·F De PaolaD Amadori
Mar 5, 2003·Journal of Immunotherapy·Laura RidolfiDino Amadori
Citations
Mar 2, 2011·Cancer Biotherapy & Radiopharmaceuticals·Robert O Dillman
Sep 22, 2007·BMC Medicine·Hirokazu KawanoYasufumi Kaneda
Nov 19, 2010·PloS One·Linh T NguyenPamela S Ohashi
May 19, 2010·World Journal of Gastroenterology : WJG·Rui-Qing PengXiao-Shi Zhang
Dec 3, 2008·Immunology Letters·Xiao-Ying LeiAn-Gang Yang
Jul 25, 2008·Clinical Colorectal Cancer·Derek G PowerNancy E Kemeny
Oct 4, 2006·Alimentary Pharmacology & Therapeutics·C EvansD Kumar
Apr 26, 2006·Urology·Jun-Qiang TianBao-Liang Ma
Oct 7, 2015·Current Colorectal Cancer Reports·Timothy J Zumwalt, Ajay Goel
Oct 27, 2007·Biochemical and Biophysical Research Communications·Takashi ShimboYasufumi Kaneda
Jan 11, 2013·Cancer Control : Journal of the Moffitt Cancer Center·Paul G ToomeyShari A Pilon-Thomas
May 11, 2016·Immune Network·Ji Sung KimSang-Bae Han
Apr 12, 2008·Expert Review of Anticancer Therapy·Imke Atreya, Markus F Neurath
Feb 23, 2020·Clinical & Translational Immunology·Qiu-Zhong PanJian-Chuan Xia
Apr 14, 2017·Oncotarget·Lei ZhangChanghui Zhou
Nov 22, 2012·Experimental and Therapeutic Medicine·Jing-Yue YangWen-Chao Liu
Oct 6, 2020·Frontiers in Immunology·Francesco ManfrediEliana Ruggiero
Jul 2, 2005·World Journal of Gastroenterology : WJG·Peng WangLu-Ming Liu
Mar 27, 2020·Frontiers in Immunology·Emilie PicardGraham Pawelec
Sep 16, 2014·Expert Review of Anticancer Therapy·Giuseppe Di CaroFederica Marchesi
Jan 5, 2012·Scandinavian Journal of Gastroenterology·Eva EllebaekPer Thor Straten
Jan 21, 2015·Cancer Immunology Research·Ajay V MakerMichael I D'Angelica
May 2, 2006·Molecular Cancer Therapeutics·Hidetoshi MimaYasufumi Kaneda
Jul 27, 2021·Molecular Therapy Oncolytics·Nuttavut SumransubEmil Lou